The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.40
Bid: 144.60
Ask: 145.00
Change: -0.40 (-0.28%)
Spread: 0.40 (0.277%)
Open: 138.00
High: 145.00
Low: 138.00
Prev. Close: 144.80
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Statement

26 Apr 2022 07:00

RNS Number : 2756J
Elementis PLC
26 April 2022
 

Elementis plc

AGM Trading Statement

 

Robust first quarter trading performance

 

Chromium strategic review

 

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 31 March 2022 and announces a strategic review of Chromium.

First Quarter Business Performance

 

Trading for the three months ended 31 March 2022 has been positive. Revenue increased approximately 7% on an underlying basis* against the prior year period, driven by pricing actions, new business wins and continued demand recovery in Personal Care.

· Coatings revenue and margins increased on the prior year period. Successful pricing actions and an improved mix more than offset lower volumes linked to supply chain disruptions and weaker industrial activity in China, as well as rising raw material, energy and logistics cost inflation.

 

· Personal Care performance improved materially as social restrictions eased further and our growth initiatives continued to gain momentum. Margins were strong due to successful pricing actions. The ramp-up of our new plant in India continues to progress at pace.

 

· In Talc, while successful pricing actions more than offset cost inflation, performance declined on the prior year period due to weaker European automotive production and a strike throughout the first quarter at our main paper customer in Finland.

 

· Chromium performance declined as an unexpected temporary plant outage impacted volumes. Pricing continued to show positive momentum, more than offsetting increased costs.

 

Cash generation in the first quarter was in line with expectations and the Group's business model remains highly cash generative.

 

Strategic Update

 

The Group today announces it has initiated a strategic review of its Chromium business. The review will establish whether the full potential of Chromium can best be delivered as part of Elementis, or, via a full or partial divestment. It will consider the practicality of all options, whilst prioritising the best interests of all stakeholders, including employees, customers and shareholders.

 

Outlook

 

The year has started well with improved profitability, driven by self-help actions, positive momentum in Personal Care and underlying strength in Coatings. For the full year, we are confident that further strategic progress will drive improved financial performance and a reduction in leverage, in line with expectations.

 

Commenting on today's announcement, CEO, Paul Waterman said,

 

"We have made a good start to the year and will continue to maintain our focus on self-help actions and effectively managing the challenging external supply chain environment, demand uncertainties and rising inflation. We remain on-track to deliver $50m of new business opportunities, over 20 new products and progress towards $10m of additional efficiency savings by 2023.

 

In line with our Innovation, Growth and Efficiency strategy, we have focused Elementis on high quality Personal Care, Coatings and Talc performance additive businesses which hold enduring positions of strength in growing markets, and today represent approximately 90% of Group profits. In this context we will execute a strategic review of our Chromium business to determine whether Elementis remains the best owner."

 

Enquiries

Elementis

James Curran, Investor Relations 020 7067 2994

Tulchan

Martin Robinson 020 7353 4200

Olivia Peters

 

Notes: Adjusted for constant currency impact

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSDSEIEFIF
Date   Source Headline
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.